Pain in amyotrophic lateral sclerosis: a narrative review

Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative condition characterized by loss of motor neurons, resulting in motor weakness of the limbs and/or bulbar muscles. Pain is a prevalent but neglected symptom of ALS, and it has a significant negative impact on the quality o...

Full description

Bibliographic Details
Main Author: Soyoung Kwak
Format: Article
Language:English
Published: Yeungnam University College of Medicine, Yeungnam University Institute Medical Science 2022-07-01
Series:Journal of Yeungnam Medical Science
Subjects:
Online Access:http://www.e-jyms.org/upload/pdf/jyms-2022-00332.pdf
_version_ 1828300756297449472
author Soyoung Kwak
author_facet Soyoung Kwak
author_sort Soyoung Kwak
collection DOAJ
description Amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative condition characterized by loss of motor neurons, resulting in motor weakness of the limbs and/or bulbar muscles. Pain is a prevalent but neglected symptom of ALS, and it has a significant negative impact on the quality of life of patients and their caregivers. This review outlines the epidemiology, clinical characteristics, underlying mechanisms, and management strategies of pain in ALS to improve clinical practice and patient outcomes related to pain. Pain is a prevalent symptom among patients with ALS, with a variable reported prevalence. It may occur at any stage of the disease and can involve any part of the body without a specific pattern. Primary pain includes neuropathic pain and pain from spasticity or cramps, while secondary pain is mainly nociceptive, occurring with the progression of muscle weakness and atrophy, prolonged immobility causing degenerative changes in joints and connective tissue, and long-term home mechanical ventilation. Prior to treatment, the exact patterns and causes of pain must first be identified, and the treatment should be tailored to each patient. Treatment options can be classified into pharmacological treatments, including nonsteroidal anti-inflammatory drugs, antiepileptic drugs, drugs for cramps or spasticity, and opioid; and nonpharmacological treatments, including positioning, splints, joint injections, and physical therapy. The development of standardized and specific assessment tools for pain-specific to ALS is required, as are further studies on treatments to reduce pain, diminish suffering, and improve the quality of life of patients with ALS.
first_indexed 2024-04-13T13:14:15Z
format Article
id doaj.art-a4f2cbab295048948383f678237686e1
institution Directory Open Access Journal
issn 2799-8010
language English
last_indexed 2024-04-13T13:14:15Z
publishDate 2022-07-01
publisher Yeungnam University College of Medicine, Yeungnam University Institute Medical Science
record_format Article
series Journal of Yeungnam Medical Science
spelling doaj.art-a4f2cbab295048948383f678237686e12022-12-22T02:45:31ZengYeungnam University College of Medicine, Yeungnam University Institute Medical ScienceJournal of Yeungnam Medical Science2799-80102022-07-0139318118910.12701/jyms.2022.003322724Pain in amyotrophic lateral sclerosis: a narrative reviewSoyoung KwakAmyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative condition characterized by loss of motor neurons, resulting in motor weakness of the limbs and/or bulbar muscles. Pain is a prevalent but neglected symptom of ALS, and it has a significant negative impact on the quality of life of patients and their caregivers. This review outlines the epidemiology, clinical characteristics, underlying mechanisms, and management strategies of pain in ALS to improve clinical practice and patient outcomes related to pain. Pain is a prevalent symptom among patients with ALS, with a variable reported prevalence. It may occur at any stage of the disease and can involve any part of the body without a specific pattern. Primary pain includes neuropathic pain and pain from spasticity or cramps, while secondary pain is mainly nociceptive, occurring with the progression of muscle weakness and atrophy, prolonged immobility causing degenerative changes in joints and connective tissue, and long-term home mechanical ventilation. Prior to treatment, the exact patterns and causes of pain must first be identified, and the treatment should be tailored to each patient. Treatment options can be classified into pharmacological treatments, including nonsteroidal anti-inflammatory drugs, antiepileptic drugs, drugs for cramps or spasticity, and opioid; and nonpharmacological treatments, including positioning, splints, joint injections, and physical therapy. The development of standardized and specific assessment tools for pain-specific to ALS is required, as are further studies on treatments to reduce pain, diminish suffering, and improve the quality of life of patients with ALS.http://www.e-jyms.org/upload/pdf/jyms-2022-00332.pdfamyotrophic lateral sclerosismotor neuron diseasenon-motor symptomspainpalliative care
spellingShingle Soyoung Kwak
Pain in amyotrophic lateral sclerosis: a narrative review
Journal of Yeungnam Medical Science
amyotrophic lateral sclerosis
motor neuron disease
non-motor symptoms
pain
palliative care
title Pain in amyotrophic lateral sclerosis: a narrative review
title_full Pain in amyotrophic lateral sclerosis: a narrative review
title_fullStr Pain in amyotrophic lateral sclerosis: a narrative review
title_full_unstemmed Pain in amyotrophic lateral sclerosis: a narrative review
title_short Pain in amyotrophic lateral sclerosis: a narrative review
title_sort pain in amyotrophic lateral sclerosis a narrative review
topic amyotrophic lateral sclerosis
motor neuron disease
non-motor symptoms
pain
palliative care
url http://www.e-jyms.org/upload/pdf/jyms-2022-00332.pdf
work_keys_str_mv AT soyoungkwak paininamyotrophiclateralsclerosisanarrativereview